Newborn screening: early detection of Cytomegalovirus (CMV).
This law introduces the option for hospitals to administer screening tests for congenital Cytomegalovirus (CMV) in newborns up to 21 days old. It provides federal financial support to states to implement these screenings, collect data, and educate parents and medical staff about the disease. The goal is early detection and intervention, which can prevent serious health issues in children, such as hearing loss.
Key points
Introduction of optional screening for congenital Cytomegalovirus (CMV) for infants up to 21 days old in healthcare facilities.
Federal grants provided to states to cover testing costs, develop data collection systems, and run educational campaigns regarding CMV.
Increased funding for scientific research into new methods for diagnosing, preventing, and treating the CMV virus.
Expired
Citizen Poll